Metronomic capecitabine as second-line treatment in hepatocellular carcinoma after sorafenib failure.
Dig Liver Dis
; 47(6): 518-22, 2015 Jun.
Article
in En
| MEDLINE
| ID: mdl-25861840
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Phenylurea Compounds
/
Niacinamide
/
Carcinoma, Hepatocellular
/
Capecitabine
/
Liver Neoplasms
/
Antineoplastic Agents
Type of study:
Evaluation_studies
/
Observational_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Dig Liver Dis
Journal subject:
GASTROENTEROLOGIA
Year:
2015
Document type:
Article